SLC29A3, Polyclonal Antibody

Equilibrative nucleoside transporter 3; hENT3; Solute carrier family 29 member 3; SLC29A3; ENT3

For Research Use Only. Not for use in diagnostic procedures.

Polyclonal

Rabbit Ig

Rabbit

This SLC29A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 21-50 amino acids from the N-terminal region of human SLC29A3.

Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.

Vial Concentration: 0.5 (lot specific)

Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C in small aliquots to prevent freeze-thaw cycles.

Small volumes of anti-SLC29A3 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

This gene encodes a nucleoside transporter. The encoded
protein plays a role in cellular uptake of nucleosides,
nucleobases, and their related analogs. Mutations in this gene have
been associated with H syndrome, which is characterized by
cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly,
heart anomalies, and hypogonadism. A related disorder, PHID
(pigmented hypertrichosis with insulin-dependent diabetes
mellitus), has also been associated with mutations at this locus.
Alternatively spliced transcript variants have been described.

Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC)

WB~~1:1000

SLC29A3 Antibody (N-term) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the SLC29A3 antibody detected the SLC29A3 protein (arrow).

SLC29A3 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human uterus tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SLC29A3 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.

51815

solute carrier family 29 (equilibrative nucleoside transporter), member 3

equilibrative nucleoside transporter 3

Equilibrative nucleoside transporter 3

ENT3; hENT3  [Similar Products]

S29A3_HUMAN

This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010]

SLC29A3: Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter). Mediates transport of adenine, adenosine and uridine, as well as several nucleoside analog drugs, such as anticancer and antiviral agents, including cladribine, cordycepin, tubercidin and AZT. Does not transport hypoxanthine. Defects in SLC29A3 are the cause of histiocytosis- lymphadenopathy plus syndrome (HLAS). A syndrome characterized by the combination of features from 2 or more of four histiocytic disorders, originally thought to be distinct: Faisalabad histiocytosis (FHC), sinus histiocytosis with massive lymphadenopathy (SHML), H syndrome, and pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome (PHID). FHC features include joint deformities, sensorineural hearing loss, and subsequent development of generalized lymphadenopathy and swellings in the eyelids that contain histiocytes. SHML causes lymph node enlargement in children frequently accompanied by fever, leukocytosis, elevated erythrocyte sedimentation rate, and polyclonal hypergammaglobulinemia. H syndrome is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism; hearing loss is found in about half of patients. PHID is characterized by predominantly antibody-negative insulin-dependent diabetes mellitus associated with pigmented hypertrichosis and variable occurrence of other features of H syndrome. Belongs to the SLC29A/ENT transporter (TC 2.A.57) family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Membrane protein, multi-pass; Transporter; Transporter, SLC family; Membrane protein, integral

Chromosomal Location of Human Ortholog: 10q22.1

Cellular Component: late endosome membrane; lysosomal membrane; integral to membrane

Molecular Function: nucleoside transmembrane transporter activity

Biological Process: transmembrane transport

Disease: Histiocytosis-lymphadenopathy Plus Syndrome

Gass, N., et al. J Affect Disord 126 (1-2), 134-139 (2010) :
Kang, N., et al. J. Biol. Chem. 285(36):28343-28352(2010)
Li, X., et al. Zhongguo Fei Ai Za Zhi 13(5):458-463(2010)
Priya, T.P., et al. Br. J. Dermatol. 162(5):1132-1134(2010)
Cliffe, S.T., et al. Hum. Mol. Genet. 18(12):2257-2265(2009)

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.